The Continuous Glucose Monitoring (CGM) Market was valued at USD 4.98 billion in 2024 and is projected to reach USD 8.82 billion by 2032, growing at a CAGR of 7.80% during the forecast period from 2025 to 2032. This market is experiencing substantial growth, primarily driven by the rising global prevalence of diabetes, increasing obesity rates, and growing awareness of proactive glucose management. CGM systems offer a revolutionary approach to diabetes care by providing real-time, minimally invasive monitoring of blood glucose levels, enabling patients and healthcare professionals to make timely, data-driven decisions. These devices significantly reduce the risk of hypoglycemia and improve glycemic control, making them essential tools in modern diabetes management.